| Time | Title | Chairs & Speakers |
|---|---|---|
| 07:50 - 08:00 | Opening remark | Johji Inazawa (Tokyo Medical and Dental University) |
| Session 1 (Clinical application of ctDNA liquid biopsy for precision oncology ) | ||
| 08:00 - 08:20 | Advances in detection technology of ctDNA | Duhee Bang (Yonsei University) |
| 08:20 - 08:40 | ctDNA application for metastatic breast cancer | Kyong Hwa Park (Korea University) |
| 08:40 - 09:00 | Optimal selection of targeted therapy in lung cancer | Se-Hoon Lee (Sungkyunkwan University) |
| 09:00 - 09:20 | Application of ctDNA liquid biopsy in colorectal cancer | Tae-You Kim (Seoul National University) |
| Session 2 (Genomics) | ||
| 09:20 - 09:40 | Cell-of-origins and molecular stratification of human thymomas | Seongyeol Park (GENOMEinSIGHT) |
| 09:40 - 10:00 | Harnessing synthetic lethality to advance precision cancer medicine | Joo Sang Lee (Sungkyunkwan University) |
| 10:00 - 10:20 | Rare variant analysis in cancer | Youngil Koh (Seoul National University) |
| 10:20 - 10:40 | Endogenous dsRNAs as a potential response marker for the hypomethylating agents | Yoosik Kim (KAIST) |
| 10:40 - 10:50 | Coffee break | |
| Session 3 (Recent advances in the treatment) | ||
| 10:50 - 11:10 | Precision oncology - clinical practice and challenges in lung cancer | Sehhoon Park (Sungkyunkwan University) |
| 11:10 - 11:30 | Clinical trials for breast cancer focused on precision medicine | Ji-Yeon Kim (Sungkyunkwan University) |
| 11:30 - 11:50 | Chimeric antigen receptor T-cells (CAR-Ts): a versatile platform for engineered cell therapy of cancer | Dok Hyun Yoon (Ulsan University) |
| 11:50 - 12:10 | New agents in acute myeloid leukemia (AML) | Silvia Park (The Catholic University of Korea) |
| 12:10 - 13:10 | Lunch | |
| Session 4 (New targeted therapy in Oncology ) | ||
| 13:10 - 13:30 | Cutting edge of targeted therapy for advanced non-small cell lung cancer | Jin-Soo Kim (Seoul National University) |
| 13:30 - 13:50 | New targeted therapy for breast cancer | Kyung-Hun Lee (Seoul National University) |
| 13:50 - 14:10 | Targeting DNA damage repair pathway | Seock-Ah Im (Seoul National University) |
| 14:10 - 14:30 | New targeted therapy for gastric cancer | Tae Yong Kim (Seoul National University) |
| Session 5 (Precision medicine of breast cancer) | ||
| 14:30 - 14:50 | Current Address of Precision Medicine in Breast Cancer as of 2021 | Yeon Hee Park (Sungkyunkwan University |
| 14:50 - 15:10 | Liquid biopsy for breast cancer | Jisun Kim (Ulsan University) |
| 15:10 - 15:30 | Spatial omics in breast cancer using spatially resolved laser activated cell sorting | Chungwon Lee (Seoul National University) |
| 15:30 - 15:50 | Development of an NGS-based multigene assay for breast cancer prognostication | Han-Byoel Lee (Seoul National University) |
| 15:50 - 16:00 | Coffee break | |
| Session 6 (Exosomes in Cancer) | ||
| 16:00 - 16:20 | Highly efficient method to concentrate extracellular vesicles in liquid samples for cancer molecular diagnostics: ExoDiscovery by LabSpinner | Kyusang Lee (LabSpinner) |
| 16:20 - 16:40 | Next-generation AAV gene therapy platform | Seung Hee Cho (AAVATAR Therapeutics) |